Angiogenesis in gliomas

Recent Results Cancer Res. 2009:171:193-215. doi: 10.1007/978-3-540-31206-2_12.

Abstract

Angiogenesis, the sprouting of new blood vessels from preexisting blood vessels, is a hallmark of glioma progression. Malignant gliomas are among the most lethal tumors with a very dismal prognosis, despite advances in standard therapy, including surgery, radiation, and chemotherapy. The median survival of patients with malignant gliomas has changed little in the last few years and is still measured in months. In an attempt to develop new therapeutic strategies and identify the molecular mechanism involved in glioma growth and progression, there has been extraordinary scientific interest in the past 2 decades in angiogenic responses associated with gliomas. This chapter focuses on the molecular mechanism of glioma angiogenesis and summarizes some of the therapeutic approaches based on antiangiogenesis.

Publication types

  • Research Support, Non-U.S. Gov't
  • Review

MeSH terms

  • Adaptor Proteins, Signal Transducing
  • Angiogenesis Inhibitors / therapeutic use
  • Angiopoietins / physiology
  • Calcium-Binding Proteins
  • Glioma / blood supply*
  • Humans
  • Intercellular Signaling Peptides and Proteins / physiology
  • Neovascularization, Pathologic / etiology
  • Neovascularization, Pathologic / therapy*
  • Receptors, Vascular Endothelial Growth Factor / antagonists & inhibitors
  • Receptors, Vascular Endothelial Growth Factor / physiology
  • Semaphorins / physiology
  • Vascular Endothelial Growth Factor A / antagonists & inhibitors
  • Vascular Endothelial Growth Factor A / physiology

Substances

  • Adaptor Proteins, Signal Transducing
  • Angiogenesis Inhibitors
  • Angiopoietins
  • Calcium-Binding Proteins
  • DLL4 protein, human
  • Intercellular Signaling Peptides and Proteins
  • Semaphorins
  • Vascular Endothelial Growth Factor A
  • Receptors, Vascular Endothelial Growth Factor